Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia
- 15 June 2016
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 243, 207-209
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial HospitaI ((CMRPG8C0831))
This publication has 13 references indexed in Scilit:
- Neuronal Kmt2a/Mll1 Histone Methyltransferase Is Essential for Prefrontal Synaptic Plasticity and Working MemoryJournal of Neuroscience, 2015
- Individual Differences in Novelty Seeking Predict Subsequent Vulnerability to Social Defeat through a Differential Epigenetic Regulation of Brain-Derived Neurotrophic Factor ExpressionJournal of Neuroscience, 2013
- RETRACTED: The Noncoding RNA Mistral Activates Hoxa6 and Hoxa7 Expression and Stem Cell Differentiation by Recruiting MLL1 to ChromatinMolecular Cell, 2011
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysisMolecular Psychiatry, 2010
- Epigenetics of Schizophrenia2010
- Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cellsNature, 2009
- Epigenetic Regulation in Human Brain—Focus on Histone Lysine MethylationBiological Psychiatry, 2009
- Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene PromotersJournal of Neuroscience, 2007
- SnapShot: Histone-Modifying EnzymesCell, 2007
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987